Topic: Atlanta
Doctors now face board-specialty 'expiration dates' to make sure skills haven't gone staleThe next time you're at the doctor's office, take a peek at those certificates hanging on the wall. Like gallons of milk, some of them are expiring. For the first ...
Women die more often than men from heart disease because they are not systematically given the same treatment and tests, according to a French study unveiled here Tuesday.The study, carried out on 3,000 women in the French region of Franche-Comte in 2006 ...
ATLANTA (Reuters) - New research shows more patients who got drug-coated stents right after suffering a heart attack later died from heart-related problems than those who received older, cheaper bare-metal stents.Seven years after the first drug-coated stent was approved in the United ...
ATLANTA (Reuters) - When it comes to matters of the heart, women should be treated more like men."This suggests that we could reduce mortality in female patients by using more invasive procedures," said Dr. Francois Schiele, chief cardiologist at the University Hospital ...
ATLANTA (Reuters) - When it comes to matters of the heart, women should be treated more like men."This suggests that we could reduce mortality in female patients by using more invasive procedures," said Dr. Francois Schiele, chief cardiologist at the University Hospital ...
ATLANTA (Reuters) - Use of genetic screening on heart patients helped cut hospitalizations related to the widely used blood thinner warfarin by nearly a third, according to a large study that marks a step forward in the fledgling field of personalized medicine.Researchers ...
An experimental blood thinner developed by Merck and Portola Pharmaceuticals was found to be safe and effective in a mid-stage study presented Monday, with a lower incidence of serious bleeding than current drugs.The Phase II randomized trial compared the effects of betrixaban, ...
An experimental blood thinner developed by Merck and Portola Pharmaceuticals was found to be safe and effective in a mid-stage study presented Monday, with a lower incidence of serious bleeding than current drugs.The Phase II randomized trial compared the effects of betrixaban, ...
ATLANTA (Reuters) - The Novartis diabetes drug Starlix failed to reduce progression to the disease or cut down on serious heart problems in patients at high risk for both diabetes and heart disease, according to a large study released on Sunday.The 9,306-patient ...
ATLANTA (Reuters) - An experimental, minimally invasive technique to repair the most common type of heart valve problem proved to be far safer and nearly as effective as open heart surgery, meeting the primary goals of a pivotal study, researchers said on ...